|
PMID 27864633
|
, Mostafa A |
El‐Shesheny |
2017 |
|
PMID 9815209
|
V., McCullers J. A., Bethell R. C., and Webster R. G., “Characterization of influenza A/HongKong/156/97 (H5N1) Virus in a Mouse Model and Protective Effect of Zanamivir on H5N1 Infection in Mice,” The Journal of Infectious Diseases 178 (1998): 1592–1596 |
Gubareva |
1998 |
|
PMID 10221870
|
P., Haaheim L. R., and Wood J. M., “The Next Influenza Pandemic: Lessons From Hong Kong, 1997,” Emerging Infectious Diseases 5 (1999): 195–203 |
Snacken |
1999 |
|
-
|
who |
Cumulative Number of Confirmed Human Cas |
2021 |
|
PMID 17492465
|
J., Michaelis M., and Doerr H. W., “The Threat of Avian Influenza A (H5N1). Part I: Epidemiologic Concerns and Virulence Determinants,” Med Microbiol Immunol 196 (2007): 181–190 |
Jr |
2007 |
|
PMID 16409141
|
B., “Avian Flu to Human Influenza,” Annual Review of Medicine 57 (2006): 139–154 |
Lewis |
2006 |
|
PMID 18818732
In OmniVira
|
Evolutionary dynamics and emergence of panzootic H5N1 influenza viruses. |
Vijaykrishna |
2008 |
|
PMID 19802744
In OmniVira
|
Stable non-synonymous substitutions on NS gene (NS1 and NS2 proteins) of Qinghai Lake H5N1 influenza virus (Clade 2.2) after successive passages in Muscovy ducks. |
Song |
2009 |
|
PMID 21042591
|
, Xu B |
Liang |
2010 |
|
PMID 19653927
|
L., Chowell G., Schwager S |
Rivas |
2010 |
|
PMID 26341298
|
S., Suchard M. A., Baele G., Gilbert M., and Lemey P., “Bayesian Inference Reveals Host‐Specific Contributions to the Epidemic Expansion of Influenza A H5N1,” Molecular biology and evolution 32 (2015): 3264–3275 |
Trovão |
2015 |
|
PMID 21408010
In OmniVira
|
Wild bird migration across the Qinghai-Tibetan plateau: a transmission route for highly pathogenic H5N1. |
Prosser |
2011 |
|
PMID 20680395
|
A., Saurina J., Keller I., et al., “Transmission Dynamics of Highly Pathogenic Avian Influenza at Lake Constance (Europe) During the Outbreak of Winter 2005–2006,” EcoHealth 7 (2010): 275–282 |
Penny |
2010 |
|
PMID 40080593
|
, “H5N1 Avian Flu Is Spreading Rapidly in Antarctica,” Science 387 (2025): 1130–1131 |
Moutinho |
2025 |
|
PMID 40101386
|
T., Yasa S., Obeid K., et al., “Large‐Scale Computational Modelling of H5 Influenza Variants Against HA1‐Neutralising Antibodies,” eBioMedicine 114 (2025): 105632 |
Ford |
2025 |
|
PMID 40703963
|
, Buczkowski H |
Alexakis |
2025 |
|
PMID 39848246
In OmniVira
|
Receptor binding, structure, and tissue tropism of cattle-infecting H5N1 avian influenza virus hemagglutinin. |
Song |
2025 |
|
PMID 39636969
In OmniVira
|
A single mutation in bovine influenza H5N1 hemagglutinin switches specificity to human receptors. |
Lin |
2024 |
|
PMID 17124014
|
and Govorkova E. A., “H5N1 Influenza — Continuing Evolution and Spread,” New England Journal of Medicine 355 (2006): 2174–2177 |
Webster R. G. and Govorkova |
2006 |
|
PMID 16473931
|
D., Li K. S., et al., “Establishment of Multiple Sublineages of H5N1 Influenza Virus in Asia: Implications for Pandemic Control,” Proceedings of the National Academy of Sciences 103 (2006): 2845–2850 |
Chen |
2006 |
|
PMID 16007072
|
D., Zhang S. Y., et al., “H5N1 Virus Outbreak in Migratory Waterfowl,” Nature 436 (2005): 191–192 |
Chen |
2005 |
|
PMID 36695488
|
, Monne I |
Agüero |
2022 |
|
PMID 39528494
In OmniVira
|
Epidemiological data of an influenza A/H5N1 outbreak in elephant seals in Argentina indicates mammal-to-mammal transmission. |
Uhart |
2024 |
|
PMID 39535188
|
M., Nogales A., et al., “Avian Influenza A (H5N1) Virus in Dairy Cattle: Origin, Evolution, and Cross‐Species Transmission,” MBio 15 (2024): e0254224 |
Mostafa |
2024 |
|
PMID 40145745
|
, Hermann E |
Krammer |
2025 |
|
PMID 19618616
|
and Brown I. H., “History of Highly Pathogenic Avian Influenza,” Revue Scientifique et Technique de l'OIE 28 (2009): 19–38 |
Alexander D. J. and Brown |
2009 |
|
PMID 19230160
|
and Palese P., “The Biology of Influenza Viruses,” Vaccine 26 (2008): D49–D53 |
Bouvier N. M. and Palese |
2008 |
|
PMID 19884910
|
F., Shu Y., and Kawaoka Y., “H5N1 influenza Viruses: Outbreaks and Biological Properties,” Cell Research 20 (2010): 51–61 |
Neumann |
2010 |
|
PMID 7464906
|
A., Skehel J |
Wilson |
1981 |
|
PMID 20027280
|
, “Influenza A: Understanding the Viral Life Cycle,” The Yale Journal of Biology and Medicine 82 (2009): 153 |
Samji |
2009 |
|
PMID 40177627
In OmniVira
|
Genomic signatures and host adaptation of H5N1 clade 2.3.4.4b: A call for global surveillance and multi-target antiviral strategies. |
Zhang |
2025 |
|
PMID 39672179
In OmniVira
|
Novel human-type receptor-binding H5N1 virus in live poultry markets, China. |
Wen |
2025 |
|
PMID 17108965
In OmniVira
|
Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors. |
Yamada |
2006 |
|
PMID 40048540
|
, Guo J |
Wen |
2025 |
|
PMID 39737954
In OmniVira
|
A single mutation in dairy cow-associated H5N1 viruses increases receptor binding breadth. |
Good |
2024 |
|
PMID 28166830
In OmniVira
|
The T160A hemagglutinin substitution affects not only receptor binding property but also transmissibility of H5N1 clade 2.3.4 avian influenza virus in guinea pigs. |
Gu |
2017 |
|
PMID 26109724
|
M., “Expected Effect of Deleterious Mutations on within‐Host Adaptation of Pathogens,” Journal of Virology 89 (2015): 9242–9251 |
Fonville |
2015 |
|
PMID 24899203
In OmniVira
|
PB2 mutations D701N and S714R promote adaptation of an influenza H5N1 virus to a mammalian host. |
Czudai-Matwich |
2014 |
|
PMID 19651908
|
C., Holien J. K., and Barr I. G., “In Vitro Generation of Neuraminidase Inhibitor Resistance in A(H5N1) Influenza Viruses,” Antimicrobial Agents and Chemotherapy 53 (2009): 4433–4440 |
Hurt |
2009 |
|
PMID 19309695
|
and Zheng J |
Wang N. X. and Zheng |
2009 |
|
PMID 40474192
In OmniVira
|
Immediate PB2-E627K amino acid substitution after single infection of highly pathogenic avian influenza H5N1 clade 2.3.4.4b in mice. |
Kim |
2025 |
|
PMID 40023162
|
P., Vu M., and Schmidt A. G., “Antigenic Drift Expands Influenza Viral Escape Pathways From Recalled Humoral Immunity,” Immunity 58 (2025): 716–727 |
Maurer |
2025 |
|
PMID 22722205
In OmniVira
|
Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. |
Imai |
2012 |
|
PMID 17428885
|
S., De Jong M. D., and Guan Y., “Avian Influenza Virus (H5N1): A Threat to Human Health,” Clinical Microbiology Reviews 20 (2007): 243–267 |
Peiris |
2007 |
|
PMID 16494721
|
S., “Pandemic Influenza Threat and Preparedness 1,” Emerging Infectious Diseases 12 (2006): 73–77 |
Fauci |
2006 |
|
PMID 9482437
|
, Chan P |
Yuen |
1998 |
|
PMID 16556800
|
J., De Wit E., et al., “H5N1 Virus Attachment to Lower Respiratory Tract,” Science 312 (2006): 399 |
Van Riel |
2006 |
|
PMID 36944755
|
and Schultz‐Cherry S., “We Need to Keep an Eye on Avian Influenza,” Nature Reviews Immunology 23 (2023): 267–268 |
Krammer F. and Schultz‐Cherry |
2023 |
|
PMID 37326966
|
and Subbarao K., “Mammalian Infections With Highly Pathogenic Avian Influenza Viruses Renew Concerns of Pandemic Potential,” Journal of Experimental Medicine 220 (2023): e20230447 |
Gilbertson B. and Subbarao |
2023 |
|
PMID 28382157
|
, Wu X |
Wu |
2017 |
|
PMID 39945883
|
, Mercorelli B |
Bonomini |
2025 |
|
PMID 22379077
|
A., Bovin N. V., and Webster R. G., “Decreased Neuraminidase Activity Is Important for the Adaptation of H5N1 Influenza Virus to Human Airway Epithelium,” Journal of Virology 86 (2012): 4724–4733 |
Ilyushina |
2012 |
|
PMID 11257037
In OmniVira
|
Efficacy of zanamivir against avian influenza A viruses that possess genes encoding H5N1 internal proteins and are pathogenic in mammals. |
Leneva |
2001 |
|
PMID 22704956
|
A., and Zhou H. X., “Recent Progress in Structure‐based Anti‐influenza Drug Design,” Drug Discovery Today 17 (2012): 1111–1120 |
Du |
2012 |
|
PMID 18971328
|
, Miyoshi T |
Yamashita |
2008 |
|
PMID 33627391
|
K., et al., “Discovery of a Novel Specific Inhibitor Targeting Influenza A Virus Nucleoprotein With Pleiotropic Inhibitory Effects on Various Steps of the Viral Life Cycle,” Journal of Virology 95 (2021): 10–1128 |
Yang |
2021 |
|
PMID 40099807
|
S., Sehnal D., et al., “Visualizing and Analyzing 3D Biomolecular Structures Using Mol* at RCSB.Org: Influenza A H5N1 Virus Proteome Case Study,” Protein Science 34 (2025): e70093 |
Bittrich |
2025 |
|
PMID 26506405
|
, Huang J |
Wu |
2015 |
|
PMID 17481739
|
and Neyts J., “Avian influenza A (H5N1) Infection: Targets and Strategies for Chemotherapeutic Intervention,” Trends in Pharmacological Sciences 28 (2007): 280–285 |
De Clercq E. and Neyts |
2007 |
|
PMID 17266937
|
Q., Du Q. S., and Chou K. C., “Study of Drug Resistance of Chicken Influenza A Virus (H5N1) From Homology‐modeled 3D Structures of Neuraminidases,” Biochemical and Biophysical Research Communications 354 (2007): 634–640 |
Wang |
2007 |
|
PMID 39013430
|
R., Manischewitz J., et al., “Licensed H5N1 Vaccines Generate Cross‐neutralizing Antibodies Against Highly Pathogenic H5N1 Clade 2.3.4.4b Influenza Virus,” Nature Medicine 30 (2024): 2771–2776 |
Khurana |
2024 |
|
-
|
WHO , Zoonotic Influenza: Candidate Vaccine Viruses and Potency Testing Reagents, World Health Organization. |
WHO |
- |
|
PMID 39693411
|
, Hatta Y |
Hatta |
2024 |
|
PMID 34182569
|
S., O'Halloran J. A., Kalaidina E., et al., “SARS‐CoV‐2 mRNA Vaccines Induce Persistent Human Germinal Centre Responses,” Nature 596 (2021): 109–113 |
Turner |
2021 |
|
PMID 39690742
|
, Shimizu T |
Kawai |
2025 |
|
PMID 36006890
|
‐H |
Kim K.‐H |
2022 |
|
PMID 26199334
|
M., Cathcart A. L., Pujanauski L. M., Qi L., Kash J. C., and Taubenberger J. K., “An Intranasal Virus‐Like Particle Vaccine Broadly Protects Mice From Multiple Subtypes of Influenza A Virus,” MBio 6 (2015): e01044 |
Schwartzman |
2015 |
|
PMID 37994795
|
, He Y |
Kong |
2024 |
|
PMID 40006750
|
and Safwat M., “Multivalent Inactivated Vaccine Protects Chickens From Distinct Clades of Highly Pathogenic Avian Influenza Subtypes H5N1 and H5N8,” Vaccines 13 (2025): 204 |
Kilany W. H. and Safwat |
2025 |
|
PMID 40320528
|
‐H |
Song J.‐H |
2025 |
|
PMID 41091914
|
, Wang L |
Lasrado |
2025 |
|
PMID 20215132
|
R., “Oseltamivir in Human Avian Influenza Infection,” Journal of Antimicrobial Chemotherapy 65 (2010): ii25–ii33 |
Smith |
2010 |
|
PMID 40048526
|
L., Baylor N. W., Katz R., et al., “Prepare Now for a Potential H5N1 Pandemic,” Science 387 (2025): 1047 |
Goodman |
2025 |
|
PMID 38977017
In OmniVira
|
Pathogenicity and transmissibility of bovine H5N1 influenza virus. |
Eisfeld |
2024 |
|
PMID 39111311
|
S., et al., “H5N1 influenza: Urgent Questions and Directions,” Cell 187 (2024): 4546–4548 |
Moratorio |
2024 |
|
PMID 38734891
|
and Spackman E., “Epitopes in the HA and NA of H5 and H7 Avian Influenza Viruses That Are Important for Antigenic Drift,” FEMS Microbiology Reviews 48 (2024): fuae014 |
Luczo J. M. and Spackman |
2024 |
|
PMID 39134084
|
G., Barton Behravesh C., Cunningham A. A., et al., “The Panzootic Spread of Highly Pathogenic Avian Influenza H5N1 Sublineage 2.3.4.4b: A Critical Appraisal of One Health Preparedness and Prevention,” The Lancet Infectious Diseases 24 (2024): e774–e781 |
Koopmans |
2024 |